Vasectomy Reversal More Cost-Effective Than IVF
New research suggests that vasectomy reversal is a more cost-effective option for couples wishing to conceive after a vasectomy, especially if the female partner is under 40. The study found that reversal has higher pregnancy rates and lower average costs compared to assisted reproductive technologies like IVF. Researchers advocate for considering vasectomy reversal as the initial approach before exploring more expensive ART options.
- ▪Vasectomy reversal is more cost-effective than IVF for couples post-vasectomy.
- ▪Couples with female partners under 40 achieved a pregnancy rate of 91.7% with reversal compared to 83.2% with ART.
- ▪The average cost for vasectomy reversal is significantly lower than that of IVF and ICSI procedures.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/vasectomy-reversal-more-cost-effective-than-ivf-2026a1000fwz?src=rss |
| Publication time | Mon, 18 May 2026 03:56:28 EDT |
| Retrieval time | 2026-05-18T08:04:56.128Z |
| Last seen | 2026-05-18T08:04:56.128Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 179zbco4ILZ9 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Vasectomy reversal is the most cost-effective strategy for couples post-vasectomy, particularly when the female partner is younger than 40 years, new research presented at the American Urological Association (AUA) 2026 Annual Meeting indicates.Researchers led by Dhruv Puri, MD, a urology resident with UC San Diego Health, looked at the cost-effectiveness equation in the context of employers’ caps on employees’ fertility benefits.More employers who offer the benefits are capping them, the researchers wrote in their abstract, leaving postvasectomy couples who want to conceive with the choices of microsurgical vasectomy reversal or direct testicular sperm extraction (TESA) with in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).Although assisted reproductive therapy (ART)…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
